Anzeige
Mehr »
Login
Dienstag, 23.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
330 Leser
Artikel bewerten:
(1)

Aino Health AB (publ): Aino Health interim report January-June 2021

This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail.

A continued focus on Sweden, SaaS subscriptions increase, Largest ever investment in sales and marketing

April - June 2021

  • Net sales were KSEK 5,976 (5,744)
  • Profit/loss after financial items was KSEK -3,012 (-4,565)
  • The operating result was KSEK -2,776 (-4,251)
  • Earnings per share were SEK -0.1 (-0.3)

January - June 2021

  • Net sales were KSEK 11,746 (11,829)
  • Profit/loss after financial items was KSEK -6,582 (-8,135)
  • The operating result was KSEK -6,130 (-9,239)
  • Earnings per share were SEK -0.2 (-0.5)

At the end of Q2 2021, the company had about MSEK 2.1 in accounts receivable from result-based contracts, accrued during Q42018-Q42020, of which SEK 2 million have been recognised as revenue during Q4 2019 and Q4 2020.

During the past quarter, we have had a continued focus on sales, which has resulted in a growing sales pipeline.

Systematic investment for growth
To further focus on sales, we performed a directed new share issue during the quarter and initiated a partnership with Megadeals International AB, who will be working with us going forward to support our sales.

We have signed a new contract regarding our SaaS solution Health Manager with Adecco Sweden AB, for a pilot project extending over six months and encompassing 900 users. After the initial project, there is an option for extension and increasing the number of users.

Expanded offer
On the partner side, we have expanded our ecosystem through a contract with the Swedish health tech company Zebrain, who offers online coaching. Thus, we have expanded our offer to encompass coaching services online. It is our ambition to offer our clients a platform and an ecosystem that covers all the needs related to caring for employees' health, commitment, and sick leave. This partnership is one step in that direction, making things easier for our clients.

As regards the company's cash flow, its status is as planned.

SaaS subscriptions continue to increase
As of June 30, we have 53,000 subscribers.

Jyrki Eklund
CEO and President
Aino Health AB

The information contained herein is such as shall be made public by Aino Health AB (publ), in accordance with the EU Market Abuse Regulation. This information was made public, through the agency of Jyrki Eklund, CEO and President of Aino Health AB, at 08.30 AM CET on August 17, 2021.

For more information:
Jyrki Eklund, CEO Aino Health, Phone: +358 40 042 4221

Certified adviser
Erik Penser Bank
+46 8 463 83 00
certifiedadviser@penser.se

About Aino Health.

Attachments

  • PR Aino Q2-2021 ENG (https://ml-eu.globenewswire.com/Resource/Download/ae2ab0e3-7c56-4f4b-9605-aa8da3eb2ed5)
  • Aino Q2 2021-ENG (https://ml-eu.globenewswire.com/Resource/Download/d2162e63-6a27-4342-be3d-dcd030378ef9)

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2021 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.